{{Rsnum
|rsid=17601241
|Gene=CYP19A1
|Chromosome=15
|position=51215677
|Orientation=plus
|GMAF=0.07576
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=CYP19A1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.9 | 12.4 | 86.7
| HCB | 0.0 | 2.9 | 97.1
| JPT | 0.0 | 1.8 | 98.2
| YRI | 0.0 | 4.8 | 95.2
| ASW | 0.0 | 8.8 | 91.2
| CHB | 0.0 | 2.9 | 97.1
| CHD | 0.0 | 4.6 | 95.4
| GIH | 0.0 | 25.7 | 74.3
| LWK | 0.0 | 7.3 | 92.7
| MEX | 5.2 | 31.0 | 63.8
| MKK | 1.3 | 12.8 | 85.9
| TSI | 0.0 | 15.7 | 84.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=19478482
|Title=Genetic variation of CYP19 (aromatase) gene influences age at onset of Alzheimer's disease in women
}}

{{PMID Auto
|PMID=18603647
|Title=Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response.
|OA=1
}}

{{PMID Auto
|PMID=18941913
|Title=Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
|OA=1
}}

{{PMID Auto
|PMID=19015200
|Title=Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}